1	Angiogenesis	Angiogenesis	B-NP	NN	O	0	ROOT	3	Angiogenesis
2	associated	associate	B-VP	VBN	O	1	NMOD	0
3	with	with	B-PP	IN	O	2	VMOD	0
4	visceral	visceral	B-NP	JJ	O	8	NMOD	0
5	and	and	I-NP	CC	O	8	NMOD	0
6	subcutaneous	subcutaneous	I-NP	JJ	O	8	NMOD	0
7	adipose	adipose	I-NP	NN	O	8	NMOD	0
8	tissue	tissue	I-NP	NN	O	3	PMOD	0
9	in	in	B-PP	IN	O	8	NMOD	0
10	severe	severe	B-NP	JJ	O	12	NMOD	0
11	human	human	I-NP	JJ	O	12	NMOD	0
12	obesity	obesity	I-NP	NN	O	9	PMOD	0
13	.	.	O	.	O	1	P	0

1	OBJECTIVE	OBJECTIVE	B-NP	NN	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	The	The	B-NP	DT	O	4	NMOD	0
4	expansion	expansion	I-NP	NN	O	8	SUB	2	expansion
5	of	of	B-PP	IN	O	4	NMOD	0
6	adipose	adipose	B-NP	NN	O	7	NMOD	0
7	tissue	tissue	I-NP	NN	O	5	PMOD	0
8	is	be	B-VP	VBZ	O	1	NMOD	0
9	linked	link	I-VP	VBN	O	8	VC	16	linked
10	to	to	B-PP	TO	O	9	VMOD	0
11	the	the	B-NP	DT	O	12	NMOD	0
12	development	development	I-NP	NN	O	10	PMOD	2	development
13	of	of	B-PP	IN	O	12	NMOD	0
14	its	its	B-NP	PRP$	O	15	NMOD	0
15	vasculature	vasculature	I-NP	NN	O	13	PMOD	0
16	.	.	O	.	O	8	P	0

1	However	However	B-ADVP	RB	O	11	VMOD	0
2	,	,	O	,	O	11	P	0
3	the	the	B-NP	DT	O	4	NMOD	0
4	regulation	regulation	I-NP	NN	O	11	SUB	16	regulation
5	of	of	B-PP	IN	O	4	NMOD	0
6	adipose	adipose	B-NP	NN	O	8	NMOD	0
7	tissue	tissue	I-NP	NN	O	8	NMOD	0
8	angiogenesis	angiogenesis	I-NP	NN	O	5	PMOD	3	angiogenesis
9	in	in	B-PP	IN	O	4	NMOD	0
10	humans	human	B-NP	NNS	O	9	PMOD	0
11	has	have	B-VP	VBZ	O	0	ROOT	0
12	not	not	I-VP	RB	O	11	VMOD	0
13	been	be	I-VP	VBN	O	11	VC	0
14	extensively	extensively	I-VP	RB	O	13	VMOD	0
15	studied	study	I-VP	VBN	O	13	VC	0
16	.	.	O	.	O	11	P	0

1	Our	Our	B-NP	PRP$	O	2	NMOD	0
2	aim	aim	I-NP	NN	O	3	SUB	0
3	was	be	B-VP	VBD	O	0	ROOT	0
4	to	to	B-VP	TO	O	5	VMOD	0
5	compare	compare	I-VP	VB	O	3	PRD	0
6	the	the	B-NP	DT	O	7	NMOD	0
7	angiogenesis	angiogenesis	I-NP	NN	O	5	OBJ	3	angiogenesis
8	associated	associate	B-VP	VBN	O	7	NMOD	0
9	with	with	B-PP	IN	O	8	VMOD	0
10	subcutaneous	subcutaneous	B-NP	JJ	O	12	NMOD	0
11	adipose	adipose	I-NP	NN	O	12	NMOD	0
12	tissue	tissue	I-NP	NN	O	19	NMOD	0
13	(	(	O	(	O	15	DEP	0
14	SAT	SAT	B-NP	NN	B-protein	15	DEP	0
15	)	)	O	)	O	12	NMOD	0
16	and	and	O	CC	O	19	NMOD	0
17	visceral	visceral	B-NP	JJ	O	19	NMOD	0
18	adipose	adipose	I-NP	NN	O	19	NMOD	0
19	tissue	tissue	I-NP	NN	O	9	PMOD	0
20	(	(	O	(	O	22	DEP	0
21	VAT	VAT	B-NP	NN	B-protein	22	DEP	0
22	)	)	O	)	O	19	NMOD	0
23	from	from	B-PP	IN	O	19	NMOD	0
24	the	the	B-NP	DT	O	27	NMOD	0
25	same	same	I-NP	JJ	O	27	NMOD	0
26	obese	obese	I-NP	JJ	O	27	NMOD	0
27	patients	patient	I-NP	NNS	O	23	PMOD	0
28	in	in	B-PP	IN	O	27	NMOD	0
29	an	an	B-NP	DT	O	32	NMOD	0
30	in	in	I-NP	FW	O	31	AMOD	0
31	vivo	vivo	I-NP	FW	O	32	NMOD	0
32	model	model	I-NP	NN	O	28	PMOD	0
33	.	.	O	.	O	3	P	0

1	RESEARCH	RESEARCH	B-NP	NN	O	4	NMOD	0
2	DESIGN	DESIGN	I-NP	NN	O	4	NMOD	0
3	AND	AND	I-NP	CC	O	4	NMOD	0
4	METHODS	METHODS	I-NP	NNS	O	0	ROOT	0
5	:	:	O	:	O	4	P	0
6	Adipose	Adipose	B-NP	NN	O	8	NMOD	0
7	tissue	tissue	I-NP	NN	O	8	NMOD	0
8	samples	sample	I-NP	NNS	O	39	SUB	0
9	from	from	B-PP	IN	O	8	NMOD	0
10	visceral	visceral	B-NP	JJ	O	15	NMOD	0
11	(	(	O	(	O	13	DEP	0
12	VAT	VAT	B-NP	NN	B-protein	13	DEP	0
13	)	)	O	)	O	10	NMOD	0
14	and	and	O	CC	O	15	NMOD	0
15	subcutaneous	subcutaneous	B-NP	JJ	O	9	PMOD	0
16	(	(	O	(	O	18	DEP	0
17	SAT	SAT	B-NP	NN	O	18	DEP	0
18	)	)	O	)	O	15	AMOD	0
19	sites	site	B-NP	NNS	O	15	NMOD	0
20	,	,	O	,	O	15	P	0
21	obtained	obtain	B-VP	VBN	O	15	NMOD	19	obtained
22	from	from	B-PP	IN	O	21	VMOD	0
23	36	36	B-NP	CD	O	25	NMOD	0
24	obese	obese	I-NP	JJ	O	25	NMOD	0
25	patients	patient	I-NP	NNS	O	22	PMOD	0
26	(	(	O	(	O	34	DEP	0
27	mean	mean	B-NP	JJ	O	30	NMOD	0
28	BMI	BMI	I-NP	NN	O	30	NMOD	0
29	46.5	46.5	I-NP	CD	O	30	NMOD	0
30	kg/m	kg/m	I-NP	NN	O	34	DEP	0
31	(	(	O	(	O	33	DEP	0
32	2	2	B-NP	CD	O	33	DEP	0
33	)	)	O	)	O	30	NMOD	0
34	)	)	O	)	O	25	NMOD	0
35	during	during	B-PP	IN	O	25	NMOD	0
36	bariatric	bariatric	B-NP	JJ	O	37	NMOD	0
37	surgery	surgery	I-NP	NN	O	35	PMOD	0
38	,	,	O	,	O	8	P	0
39	were	be	B-VP	VBD	O	4	NMOD	0
40	layered	layer	I-VP	VBN	O	39	VC	19	layered
41	on	on	B-PP	IN	O	40	VMOD	0
42	chick	chick	B-NP	NN	O	44	NMOD	0
43	chorioallantoic	chorioallantoic	I-NP	JJ	O	44	NMOD	0
44	membrane	membrane	I-NP	NN	O	41	PMOD	0
45	(	(	O	(	O	47	DEP	0
46	CAM	CAM	B-NP	NN	B-protein	47	DEP	0
47	)	)	O	)	O	44	NMOD	0
48	.	.	O	.	O	4	P	0

1	RESULTS	RESULTS	B-NP	NNS	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	Both	Both	O	CC	O	6	NMOD	0
4	SAT	SAT	B-NP	NN	B-protein	6	NMOD	0
5	and	and	I-NP	CC	O	6	NMOD	0
6	VAT	VAT	I-NP	NN	B-protein	7	SUB	0
7	expressed	express	B-VP	VBD	O	1	NMOD	0
8	angiogenic	angiogenic	B-NP	JJ	B-protein	9	NMOD	3	angiogenic
9	factors	factor	I-NP	NNS	I-protein	7	OBJ	0
10	without	without	B-PP	IN	O	7	VMOD	0
11	significant	significant	B-NP	JJ	O	12	NMOD	0
12	difference	difference	I-NP	NN	O	10	PMOD	0
13	for	for	B-PP	IN	O	12	NMOD	0
14	vascular	vascular	B-NP	JJ	B-protein	17	NMOD	0
15	endothelial	endothelial	I-NP	JJ	I-protein	17	NMOD	0
16	growth	growth	I-NP	NN	I-protein	17	NMOD	0
17	factor	factor	I-NP	NN	I-protein	21	NMOD	0
18	(	(	O	(	O	20	DEP	0
19	VEGF	VEGF	B-NP	NN	B-protein	20	DEP	0
20	)	)	O	)	O	17	NMOD	0
21	expression	expression	B-NP	NN	O	13	PMOD	9	expression
22	.	.	O	.	O	1	P	0

1	Adipose	Adipose	B-NP	NN	O	2	NMOD	0
2	tissue	tissue	I-NP	NN	O	3	SUB	0
3	layered	layer	B-VP	VBD	O	0	ROOT	19	layered
4	on	on	B-PP	IN	O	3	VMOD	0
5	CAM	CAM	B-NP	NN	B-protein	6	SUB	0
6	stimulated	stimulate	B-VP	VBD	O	4	SBAR	17	stimulated
7	angiogenesis	angiogenesis	B-NP	NN	O	6	OBJ	3	angiogenesis
8	.	.	O	.	O	3	P	0

1	Angiogenic	Angiogenic	B-NP	JJ	O	2	NMOD	3	Angiogenic
2	stimulation	stimulation	I-NP	NN	O	3	SUB	17	stimulation
3	was	be	B-VP	VBD	O	0	ROOT	0
4	macroscopically	macroscopically	B-ADJP	RB	O	5	AMOD	0
5	detectable	detectable	I-ADJP	JJ	O	3	PRD	0
6	,	,	O	,	O	3	P	0
7	with	with	B-PP	IN	O	3	VMOD	0
8	engulfment	engulfment	B-NP	NN	O	7	PMOD	0
9	of	of	B-PP	IN	O	8	NMOD	0
10	the	the	B-NP	DT	O	11	NMOD	0
11	samples	sample	I-NP	NNS	O	9	PMOD	0
12	,	,	O	,	O	3	P	0
13	in	in	B-PP	IN	O	3	VMOD	0
14	39	39	B-NP	CD	O	15	NMOD	0
15	%	%	I-NP	NN	O	13	PMOD	0
16	and	and	O	CC	O	3	VMOD	0
17	was	be	B-VP	VBD	O	3	VMOD	0
18	evidenced	evidence	I-VP	VBN	O	17	VC	0
19	by	by	B-PP	IN	O	18	VMOD	0
20	angiography	angiography	B-NP	NN	O	19	PMOD	0
21	in	in	B-PP	IN	O	20	NMOD	0
22	59	59	B-NP	CD	O	23	NMOD	0
23	%	%	I-NP	NN	O	21	PMOD	0
24	of	of	B-PP	IN	O	23	NMOD	0
25	the	the	B-NP	DT	O	26	NMOD	0
26	samples	sample	I-NP	NNS	O	24	PMOD	0
27	.	.	O	.	O	3	P	0

1	A	A	B-NP	DT	O	2	NMOD	0
2	connection	connection	I-NP	NN	O	9	SUB	15	connection
3	between	between	B-PP	IN	O	2	NMOD	0
4	CAM	CAM	B-NP	NN	B-protein	8	NMOD	0
5	and	and	I-NP	CC	O	8	NMOD	0
6	adipose	adipose	I-NP	NN	O	8	NMOD	0
7	tissue	tissue	I-NP	NN	O	8	NMOD	0
8	vessels	vessel	I-NP	NNS	O	3	PMOD	0
9	was	be	B-VP	VBD	O	0	ROOT	0
10	evidenced	evidence	I-VP	VBN	O	9	VC	0
11	by	by	B-PP	IN	O	10	VMOD	0
12	immunohistochemistry	immunohistochemistry	B-NP	NN	O	11	PMOD	0
13	,	,	O	,	O	10	P	0
14	with	with	B-PP	IN	O	10	VMOD	0
15	recruitment	recruitment	B-NP	NN	O	14	PMOD	14	recruitment
16	of	of	B-PP	IN	O	15	NMOD	0
17	both	both	B-NP	CC	O	22	NMOD	0
18	avian	avian	I-NP	JJ	O	22	NMOD	0
19	and	and	I-NP	CC	O	22	NMOD	0
20	human	human	I-NP	JJ	B-cell_type	22	NMOD	0
21	endothelial	endothelial	I-NP	JJ	I-cell_type	22	NMOD	0
22	cells	cell	I-NP	NNS	I-cell_type	16	PMOD	0
23	.	.	O	.	O	9	P	0

1	The	The	B-NP	DT	O	3	NMOD	0
2	angiogenic	angiogenic	I-NP	JJ	O	3	NMOD	3	angiogenic
3	potency	potency	I-NP	NN	O	7	SUB	0
4	of	of	B-PP	IN	O	3	NMOD	0
5	adipose	adipose	B-NP	NN	O	6	NMOD	0
6	tissue	tissue	I-NP	NN	O	4	PMOD	0
7	was	be	B-VP	VBD	O	0	ROOT	0
8	not	not	O	RB	O	7	VMOD	0
9	related	related	B-ADJP	JJ	O	7	PRD	0
10	to	to	B-PP	TO	O	9	AMOD	0
11	its	its	B-NP	PRP$	O	12	NMOD	0
12	localization	localization	I-NP	NN	O	10	PMOD	14	localization
13	(	(	O	(	O	30	DEP	0
14	with	with	B-PP	IN	O	30	DEP	0
15	an	an	B-NP	DT	O	17	NMOD	0
16	angiogenic	angiogenic	I-NP	JJ	O	17	NMOD	3	angiogenic
17	stimulation	stimulation	I-NP	NN	O	26	NMOD	17	stimulation
18	in	in	B-PP	IN	O	17	NMOD	0
19	60	60	B-NP	CD	O	20	NMOD	0
20	%	%	I-NP	NN	O	18	PMOD	0
21	of	of	B-PP	IN	O	20	NMOD	0
22	SAT	SAT	B-NP	NN	O	23	NMOD	0
23	samples	sample	I-NP	NNS	O	21	PMOD	0
24	and	and	O	CC	O	26	NMOD	0
25	61	61	B-NP	CD	O	26	NMOD	0
26	%	%	I-NP	NN	O	14	PMOD	0
27	of	of	B-PP	IN	O	26	NMOD	0
28	VAT	VAT	B-NP	NN	O	29	NMOD	0
29	samples	sample	I-NP	NNS	O	27	PMOD	0
30	)	)	O	)	O	12	NMOD	0
31	or	or	B-PP	CC	O	10	PMOD	0
32	to	to	B-PP	TO	O	10	PMOD	0
33	adipocyte	adipocyte	B-NP	NN	O	34	NMOD	0
34	size	size	I-NP	NN	O	37	NMOD	0
35	or	or	O	CC	O	37	NMOD	0
36	inflammatory	inflammatory	B-NP	JJ	O	37	NMOD	0
37	infiltrate	infiltrate	I-NP	NN	O	32	PMOD	0
38	assessed	assess	B-VP	VBN	O	37	NMOD	0
39	in	in	B-PP	IN	O	38	VMOD	0
40	adipose	adipose	B-NP	NN	O	41	NMOD	0
41	samples	sample	I-NP	NNS	O	39	PMOD	0
42	before	before	B-PP	IN	O	41	NMOD	0
43	the	the	B-NP	DT	O	44	NMOD	0
44	graft	graft	I-NP	NN	O	42	PMOD	0
45	on	on	B-PP	IN	O	44	NMOD	0
46	CAM	CAM	B-NP	NN	B-protein	45	PMOD	0
47	.	.	O	.	O	7	P	0

1	Stimulation	Stimulation	B-NP	NN	O	7	SUB	17	Stimulation
2	of	of	B-PP	IN	O	1	NMOD	0
3	angiogenesis	angiogenesis	B-NP	NN	O	2	PMOD	3	angiogenesis
4	by	by	B-PP	IN	O	1	NMOD	0
5	adipose	adipose	B-NP	NN	O	6	NMOD	0
6	tissue	tissue	I-NP	NN	O	4	PMOD	0
7	was	be	B-VP	VBD	O	0	ROOT	0
8	nearly	nearly	I-VP	RB	O	7	VMOD	0
9	abolished	abolish	I-VP	VBN	O	7	VC	18	abolished
10	by	by	B-PP	IN	O	9	VMOD	0
11	bevacizumab	bevacizumab	B-NP	NN	O	10	PMOD	0
12	,	,	O	,	O	11	P	0
13	which	which	B-NP	WDT	O	11	NMOD	0
14	specifically	specifically	B-VP	RB	O	15	VMOD	0
15	targets	target	I-VP	VBZ	O	13	SBAR	16	targets
16	human	human	B-NP	JJ	B-protein	17	NMOD	0
17	VEGF	VEGF	I-NP	NN	I-protein	15	OBJ	0
18	.	.	O	.	O	7	P	0

1	CONCLUSIONS	CONCLUSIONS	B-NP	NNS	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	We	We	B-NP	PRP	O	4	SUB	0
4	have	have	B-VP	VBP	O	1	NMOD	0
5	established	establish	I-VP	VBN	O	4	VC	0
6	a	a	B-NP	DT	O	7	NMOD	0
7	model	model	I-NP	NN	O	5	OBJ	0
8	to	to	B-VP	TO	O	9	VMOD	0
9	study	study	I-VP	VB	O	7	NMOD	0
10	the	the	B-NP	DT	O	11	NMOD	0
11	regulation	regulation	I-NP	NN	O	9	OBJ	16	regulation
12	of	of	B-PP	IN	O	11	NMOD	0
13	angiogenesis	angiogenesis	B-NP	NN	O	12	PMOD	3	angiogenesis
14	by	by	B-PP	IN	O	11	NMOD	0
15	human	human	B-NP	JJ	O	17	NMOD	0
16	adipose	adipose	I-NP	NN	O	17	NMOD	0
17	tissue	tissue	I-NP	NN	O	14	PMOD	0
18	.	.	O	.	O	1	P	0

1	This	This	B-NP	DT	O	2	NMOD	0
2	model	model	I-NP	NN	O	3	SUB	0
3	highlighted	highlight	B-VP	VBD	O	0	ROOT	0
4	the	the	B-NP	DT	O	5	NMOD	0
5	role	role	I-NP	NN	O	3	OBJ	16	role
6	of	of	B-PP	IN	O	5	NMOD	0
7	VEGF	VEGF	B-NP	NN	B-protein	6	PMOD	0
8	in	in	B-PP	IN	O	5	NMOD	0
9	angiogenesis	angiogenesis	B-NP	NN	O	8	PMOD	3	angiogenesis
10	in	in	B-PP	IN	O	5	NMOD	0
11	both	both	O	CC	O	14	NMOD	0
12	SAT	SAT	B-NP	NN	B-protein	14	NMOD	0
13	and	and	I-NP	CC	O	14	NMOD	0
14	VAT	VAT	I-NP	NN	B-protein	10	PMOD	0
15	.	.	O	.	O	3	P	0

